CD274 and lung carcinoma: A meta-analysis of 15 studies, including urinary tract, soft tissue, breast, ovary, pancreatic, gastrointestinal tract, and lung carcinomas involving 7251 patients, evaluated the relationship between PD-1+ lymphocytes, PD-L1+ lymphocytes, and prognosis, but the results were controversial.